Clinical Trial Update: Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of vinorelbine and bevacizumab in older adults with stage III or stage IV non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: University of Rochester | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED